Stenham Macro Solutions Fund I has made significant updates to its offering details, as revealed in a recent SEC filing. This update is crucial as it indicates the fund's ongoing activities in the competitive hedge fund market.
Background
Stenham Macro Solutions Fund I is categorized under the pooled investment fund sector, specifically as a hedge fund. The company is registered in Guernsey and operates as a protected cell company with limited liability. The fund's recent filings include a Form D/A submitted on October 30, 2026, and a Form D filed on October 31, 2025.
What the Filing Says
The recent filing, with accession number 0002093304-26-000001, indicates that the fund has made amendments to its offering under Rule 506(b), which provides a "safer harbor" for private offerings. The filing also notes that the fund has raised a total of approximately $106.35 million, with an indefinite total offering amount.
Impact
This update may affect several stakeholders, including current and potential investors, as well as competitors in the hedge fund industry. The fund has indicated that it does not accept non-accredited investors, which may limit its investor base but also suggests a focus on high-net-worth individuals.
What's Next
The filing does not say what happens next.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity










